deus semaglutide Novo Nordisk CEO Mike Doustdar spoke with CNBC's Charlotte Reed about strong demand for its weight-loss drugs and a surge in new patients. 🔗Tap the link in bio to read more Semaglutide Receives FDA Approval for

A systematic review and meta-analysis published in the American Journal of Geriatric Psychiatry , which analyzed data from 2,071 participants , found that people receiving GLP-1 receptor agonists experienced modest but significant improvements in depression scores compared with placebo or other diabetes medicine s (4 The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis Go to source) Trusted Source The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis Go to source)

Jem Bolt (Founder)

Importantly, these arent just appetite effects the animals specifically reduce alcohol-seeking behavior even when food is held constant, suggesting an independent mechanism acting on reward circuitry

The drugs packaging does not mention brain fog as a side effect of Ozempic